235 related articles for article (PubMed ID: 21738572)
21. Pancreatic carcinoma cells are susceptible to noninvasive radio frequency fields after treatment with targeted gold nanoparticles.
Glazer ES; Massey KL; Zhu C; Curley SA
Surgery; 2010 Aug; 148(2):319-24. PubMed ID: 20541785
[TBL] [Abstract][Full Text] [Related]
22. Nanoparticle delivered vascular disrupting agents (VDAs): use of TNF-alpha conjugated gold nanoparticles for multimodal cancer therapy.
Shenoi MM; Iltis I; Choi J; Koonce NA; Metzger GJ; Griffin RJ; Bischof JC
Mol Pharm; 2013 May; 10(5):1683-94. PubMed ID: 23544801
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of EGFR-targeted radioimmuno-gold-nanoparticles as a theranostic agent in a tumor animal model.
Kao HW; Lin YY; Chen CC; Chi KH; Tien DC; Hsia CC; Lin MH; Wang HE
Bioorg Med Chem Lett; 2013 Jun; 23(11):3180-5. PubMed ID: 23628334
[TBL] [Abstract][Full Text] [Related]
24. Measuring Binding Kinetics of Antibody-Conjugated Gold Nanoparticles with Intact Cells.
Yin L; Yang Y; Wang S; Wang W; Zhang S; Tao N
Small; 2015 Aug; 11(31):3782-8. PubMed ID: 25865036
[TBL] [Abstract][Full Text] [Related]
25. Glucocorticoid receptor-mediated delivery of nano gold-withaferin conjugates for reversal of epithelial-to-mesenchymal transition and tumor regression.
Agarwalla P; Mukherjee S; Sreedhar B; Banerjee R
Nanomedicine (Lond); 2016 Oct; 11(19):2529-46. PubMed ID: 27622735
[TBL] [Abstract][Full Text] [Related]
26. Cetuximab: an epidermal growth factor receptor chemeric human-murine monoclonal antibody.
Harding J; Burtness B
Drugs Today (Barc); 2005 Feb; 41(2):107-27. PubMed ID: 15821783
[TBL] [Abstract][Full Text] [Related]
27. Highly specific targeting of human leukocytes using gold nanoparticle-based biologically active conjugates.
Gibbs BF; Yasinska IM; Calzolai L; Gilliland D; Sumbayev VV
J Biomed Nanotechnol; 2014 Jul; 10(7):1259-66. PubMed ID: 24804546
[TBL] [Abstract][Full Text] [Related]
28. Development and Evaluation of a Fluorescent Antibody-Drug Conjugate for Molecular Imaging and Targeted Therapy of Pancreatic Cancer.
Knutson S; Raja E; Bomgarden R; Nlend M; Chen A; Kalyanasundaram R; Desai S
PLoS One; 2016; 11(6):e0157762. PubMed ID: 27336622
[TBL] [Abstract][Full Text] [Related]
29. In vivo targeting of DNA vaccines to dendritic cells using functionalized gold nanoparticles.
Gulla SK; Rao BR; Moku G; Jinka S; Nimmu NV; Khalid S; Patra CR; Chaudhuri A
Biomater Sci; 2019 Feb; 7(3):773-788. PubMed ID: 30601510
[TBL] [Abstract][Full Text] [Related]
30. Antibody-drug gold nanoantennas with Raman spectroscopic fingerprints for in vivo tumour theranostics.
Conde J; Bao C; Cui D; Baptista PV; Tian F
J Control Release; 2014 Jun; 183():87-93. PubMed ID: 24704711
[TBL] [Abstract][Full Text] [Related]
31. A challenge for theranostics: is the optimal particle for therapy also optimal for diagnostics?
Dreifuss T; Betzer O; Shilo M; Popovtzer A; Motiei M; Popovtzer R
Nanoscale; 2015 Oct; 7(37):15175-84. PubMed ID: 26313344
[TBL] [Abstract][Full Text] [Related]
32. Biotin Decorated Gold Nanoparticles for Targeted Delivery of a Smart-Linked Anticancer Active Copper Complex: In Vitro and In Vivo Studies.
Pramanik AK; Siddikuzzaman ; Palanimuthu D; Somasundaram K; Samuelson AG
Bioconjug Chem; 2016 Dec; 27(12):2874-2885. PubMed ID: 27998075
[TBL] [Abstract][Full Text] [Related]
33. Gold nanoparticles decorated by clustered multivalent cone-glycocalixarenes actively improve the targeting efficiency toward cancer cells.
Avvakumova S; Fezzardi P; Pandolfi L; Colombo M; Sansone F; Casnati A; Prosperi D
Chem Commun (Camb); 2014 Sep; 50(75):11029-32. PubMed ID: 25101357
[TBL] [Abstract][Full Text] [Related]
34. Pharmacodynamics of DT-IgG, a dual-targeting antibody against VEGF-EGFR, in tumor xenografted mice.
Hurwitz SJ; Zhang H; Yun S; Batuwangala TD; Steward M; Holmes SD; Rycroft D; Pan L; Tighiouart M; Shin HJ; Koenig L; Wang Y; Chen ZG; Shin DM
Cancer Chemother Pharmacol; 2012 Mar; 69(3):577-90. PubMed ID: 21913035
[TBL] [Abstract][Full Text] [Related]
35. Oridonin-loaded and GPC1-targeted gold nanoparticles for multimodal imaging and therapy in pancreatic cancer.
Qiu W; Chen R; Chen X; Zhang H; Song L; Cui W; Zhang J; Ye D; Zhang Y; Wang Z
Int J Nanomedicine; 2018; 13():6809-6827. PubMed ID: 30425490
[TBL] [Abstract][Full Text] [Related]
36. Gold nanoclusters-assisted delivery of NGF siRNA for effective treatment of pancreatic cancer.
Lei Y; Tang L; Xie Y; Xianyu Y; Zhang L; Wang P; Hamada Y; Jiang K; Zheng W; Jiang X
Nat Commun; 2017 Apr; 8():15130. PubMed ID: 28440296
[TBL] [Abstract][Full Text] [Related]
37. Antibody-functionalized nanoparticles for imaging cancer: influence of conjugation to gold nanoparticles on the biodistribution of 89Zr-labeled cetuximab in mice.
Karmani L; Labar D; Valembois V; Bouchat V; Nagaswaran PG; Bol A; Gillart J; Levêque P; Bouzin C; Bonifazi D; Michiels C; Feron O; Grégoire V; Lucas S; Vander Borght T; Gallez B
Contrast Media Mol Imaging; 2013; 8(5):402-8. PubMed ID: 23740810
[TBL] [Abstract][Full Text] [Related]
38. Design and applications of gold nanoparticle conjugates by exploiting biomolecule-gold nanoparticle interactions.
Su S; Zuo X; Pan D; Pei H; Wang L; Fan C; Huang W
Nanoscale; 2013 Apr; 5(7):2589-99. PubMed ID: 23423633
[TBL] [Abstract][Full Text] [Related]
39. 177Lu-labeled antibodies for EGFR-targeted SPECT/CT imaging and radioimmunotherapy in a preclinical head and neck carcinoma model.
Liu Z; Ma T; Liu H; Jin Z; Sun X; Zhao H; Shi J; Jia B; Li F; Wang F
Mol Pharm; 2014 Mar; 11(3):800-7. PubMed ID: 24472064
[TBL] [Abstract][Full Text] [Related]
40. 99mTc-Hydrazinonicotinamide epidermal growth factor-polyethylene glycol-quantum dot imaging allows quantification of breast cancer epidermal growth factor receptor expression and monitors receptor downregulation in response to cetuximab therapy.
Jung KH; Choe YS; Paik JY; Lee KH
J Nucl Med; 2011 Sep; 52(9):1457-64. PubMed ID: 21849406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
